At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS Tampa has implemented the Ortho Vitros Anti-SARS-CoV-2 Total test which qualitatively detects an...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...